Michael Cohen

Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies

M Laird Forrest, Taryn R. Bagby, M. Forrest, 2009, Expert opinion on drug delivery.

Prostate cancer, version 2.2014.

A. D'Amico, P. Kantoff, J. Eastham, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology

David C. Miller, A. D'Amico, P. Kantoff, 2014 .

NCCN Prostate Cancer , Version 2 . 2014 Clinical Practice Guidelines in Oncology

A. D'Amico, P. Kantoff, J. Eastham, 2014 .

Detecting recurrent bladder cancer: new methods and biomarkers

M. Cohen, J. Ross, J. Ross, 2001, Expert review of molecular diagnostics.

Featured Updates to the NCCN Guidelines

Charles A Enke, James L Mohler, Michael Kuettel, 2013 .

Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.

Charles A Enke, James L Mohler, Thomas Farrington, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Daniel S. Miller, D. Bostwick, D. Grignon, 2000, Archives of pathology & laboratory medicine.

Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies

Taryn R. Bagby, Yumei Xie, M. Forrest, 2009, Expert opinion on drug delivery.